These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38581544)

  • 1. NFL and GFAP in (pre)symptomatic RVCL-S carriers: a monogenic cerebral small vessel disease.
    Wilms AE; de Boer I; Pelzer N; In't Veld SGJG; Middelkoop HAM; Teunissen CE; Terwindt GM
    J Neurol; 2024 Jul; 271(7):4138-4145. PubMed ID: 38581544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid Angiopathy.
    Rasing I; Voigt S; Koemans EA; de Kort AM; van Harten TW; van Etten ES; van Zwet EW; Stoops E; Francois C; Kuiperij HB; Klijn CJM; Schreuder FHBM; van der Weerd L; van Osch MJP; van Walderveen MAA; Verbeek MM; Terwindt GM; Wermer MJH
    Alzheimers Res Ther; 2024 Apr; 16(1):86. PubMed ID: 38654326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the utility of serum NfL, GFAP, UCHL1 and tTAU as estimates of CSF levels and diagnostic instrument in neuroinflammation and multiple sclerosis.
    Koerbel K; Maiworm M; Schaller-Paule M; Schäfer JH; Jakob J; Friedauer L; Steffen F; Bittner S; Foerch C; Yalachkov Y
    Mult Scler Relat Disord; 2024 Jul; 87():105644. PubMed ID: 38701697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum.
    Benedet AL; Milà-Alomà M; Vrillon A; Ashton NJ; Pascoal TA; Lussier F; Karikari TK; Hourregue C; Cognat E; Dumurgier J; Stevenson J; Rahmouni N; Pallen V; Poltronetti NM; Salvadó G; Shekari M; Operto G; Gispert JD; Minguillon C; Fauria K; Kollmorgen G; Suridjan I; Zimmer ER; Zetterberg H; Molinuevo JL; Paquet C; Rosa-Neto P; Blennow K; Suárez-Calvet M;
    JAMA Neurol; 2021 Dec; 78(12):1471-1483. PubMed ID: 34661615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune astrocytopathy double negative for AQP4-IgG and GFAP-IgG: Retrospective research of clinical practice, biomarkers, and pathology.
    Lin PH; Yao HY; Huang L; Fu CC; Yao XL; Lian C; Zhang SF; Lai WD; Lin GY; Liao S; Yang J; Mao ZF; Liu D; Long BY; Yue JJ; Gao C; Long YM
    CNS Neurosci Ther; 2024 Sep; 30(9):e70042. PubMed ID: 39279053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA).
    Katzdobler S; Nübling G; Klietz M; Fietzek UM; Palleis C; Bernhardt AM; Wegner F; Huber M; Rogozinski S; Schneider LS; Spruth EJ; Beyle A; Vogt IR; Brandt M; Hansen N; Glanz W; Brockmann K; Spottke A; Hoffmann DC; Peters O; Priller J; Wiltfang J; Düzel E; Schneider A; Falkenburger B; Klockgether T; Gasser T; Nuscher B; Haass C; Höglinger G; Levin J
    J Neurol; 2024 Oct; 271(10):6991-6999. PubMed ID: 39254698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL.
    Chen CH; Cheng YW; Chen YF; Tang SC; Jeng JS
    J Neuroinflammation; 2020 Apr; 17(1):124. PubMed ID: 32321529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia.
    Heller C; Foiani MS; Moore K; Convery R; Bocchetta M; Neason M; Cash DM; Thomas D; Greaves CV; Woollacott IO; Shafei R; Van Swieten JC; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonca A; Tagliavini F; Santana I; Ducharme S; Butler CR; Gerhard A; Levin J; Danek A; Frisoni G; Sorbi S; Otto M; Heslegrave AJ; Zetterberg H; Rohrer JD;
    J Neurol Neurosurg Psychiatry; 2020 Mar; 91(3):263-270. PubMed ID: 31937580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
    Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H
    Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis.
    Axelsson M; Malmeström C; Nilsson S; Haghighi S; Rosengren L; Lycke J
    J Neurol; 2011 May; 258(5):882-8. PubMed ID: 21197541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum GFAP and NfL levels in benign relapsing-remitting multiple sclerosis.
    Niiranen M; Kontkanen A; Jääskeläinen O; Tertsunen HM; Selander T; Hartikainen P; Huber N; Solje E; Haapasalo A; Kokkola T; Lohioja T; Herukka SK; Simula S; Remes AM
    Mult Scler Relat Disord; 2021 Nov; 56():103280. PubMed ID: 34627002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum GFAP as a biomarker for disease severity in multiple sclerosis.
    Abdelhak A; Huss A; Kassubek J; Tumani H; Otto M
    Sci Rep; 2018 Oct; 8(1):14798. PubMed ID: 30287870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity.
    Högel H; Rissanen E; Barro C; Matilainen M; Nylund M; Kuhle J; Airas L
    Mult Scler; 2020 Feb; 26(2):210-219. PubMed ID: 30570436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia.
    Ingannato A; Bagnoli S; Mazzeo S; Giacomucci G; Bessi V; Ferrari C; Sorbi S; Nacmias B
    Front Endocrinol (Lausanne); 2024; 15():1375302. PubMed ID: 38654932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-based biomarkers of neuronal and glial injury in active major neuropsychiatric systemic lupus erythematosus.
    Kammeyer R; Chapman K; Furniss A; Hsieh E; Fuhlbrigge R; Ogbu EA; Boackle S; Zell J; Nair KV; Borko TL; Cooper JC; Bennett JL; Piquet AL
    Lupus; 2024 Sep; 33(10):1116-1129. PubMed ID: 39148457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental value of serum neurofilament light chain and glial fibrillary acidic protein as blood-based biomarkers for predicting functional outcome in severe acute ischemic stroke.
    Vollmuth C; Fiessler C; Montellano FA; Kollikowski AM; Essig F; Oeckl P; Barba L; Steinacker P; Schulz C; Ungethüm K; Wolf J; Pham M; Schuhmann MK; Heuschmann PU; Haeusler KG; Stoll G; Otto M; Neugebauer H
    Eur Stroke J; 2024 Sep; 9(3):751-762. PubMed ID: 38400734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluid Biomarkers in Individuals at Risk for Genetic Prion Disease up to Disease Conversion.
    Vallabh SM; Mortberg MA; Allen SW; Kupferschmid AC; Kivisakk P; Hammerschlag BL; Bolling A; Trombetta BA; Devitte-McKee K; Ford AM; Sather LE; Duffy G; Rivera A; Gerber J; McManus AJ; Minikel EV; Arnold SE
    Neurology; 2024 Jul; 103(2):e209506. PubMed ID: 38896810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
    Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
    Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy.
    van Ballegoij WJC; van de Stadt SIW; Huffnagel IC; Kemp S; Willemse EAJ; Teunissen CE; Engelen M
    Ann Clin Transl Neurol; 2020 Nov; 7(11):2127-2136. PubMed ID: 33047897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between blood and cerebrospinal fluid glial fibrillary Acidic protein levels: The effect of sample stability.
    Simrén J; Weninger H; Brum WS; Khalil S; Benedet AL; Blennow K; Zetterberg H; Ashton NJ
    Alzheimers Dement; 2022 Oct; 18(10):1988-1992. PubMed ID: 36102852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.